ESO Stroke ESOC 2018

Abstract submission for ESOC2018 closes on Monday, 22 January 2018 at 23:59. Abstract topics are listed below. All abstracts must be submitted via the official abstract submission website where you can also find the complete submission guidelines..

01.ONGOING TRIALS

02.CLINICAL TRIAL RESULTS – ACUTE MANAGEMENT – NEITHER THROMBOLYSIS NOR THROMBECTOMY

03.CLINICAL TRIAL RESULTS – ACUTE MANAGEMENT – THROMBOLYSIS OR THROMBECTOMY

04.CLINICAL TRIAL RESULTS – PREVENTION

05.CLINICAL TRIAL RESULTS – REHABILITATION & RECOVERY

06.THROMBOLYSIS – EXCLUDING CLINICAL TRIAL RESULTS

07.HYPERACUTE MANAGEMENT – EXCLUDING CLINICAL TRIAL RESULTS

08.NEUROINTERVENTION – EXCLUDING CLINICAL TRIAL RESULTS

09.REHABILITATION AND RECOVERY – EXCLUDING CLINICAL TRIAL RESULTS

10.PREVENTION – EXCLUDING CLINICAL TRIAL RESULTS

11.IMAGING – HYPERACUTE

12.IMAGING – NON-ACUTE INCLUDING NEUROSONOLOGY

13.SERVICE ORGANISATION

14.NURSING, ALLIED HEALTH PROFESSIONALS AND CARERS

15.DIAGNOSIS/INVESTIGATION OF STROKE ETIOLOGY

16.EPIDEMIOLOGY OF STROKE

17.PROGNOSIS AND OUTCOME AFTER STROKE

18.PATHOPHYSIOLOGY OF STROKE

19.RISK FACTORS FOR STROKE

20.RARE CAUSES, STROKE IN THE YOUNG

21.INTRACEREBRAL HEMORRHAGE

22.ATRIAL FIBRILLATION, CARDIOEMBOLISM & HEART-BRAIN INTERACTIONS

23.COGNITION AND VASCULAR COGNITIVE IMPAIRMENT

24.SMALL VESSEL DISEASE

25.SAH, ANEURYSMS AND VASCULAR MALFORMATIONS

26.APHASIA, NEGLECT AND OTHER CORTICAL DEFICITS

27.WOMEN AND STROKE

28.YOUNG STROKE PHYSICIANS AND RESEARCHERS: RESEARCH DESIGN WORKSHOP FOR STUDIES IN DEVELOPMENT * (Please see below)

29.EXPERIMENTAL/TRANSLATIONAL MEDICINE

30.GENETICS, ‘OMICS AND BIOMARKERS

31. SYSTEMATIC REVIEW AND META-ANALYSIS

32.CASE REPORTS